Literature DB >> 28122876

Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI.

Natania A Crane1, Lisanne M Jenkins1, Runa Bhaumik1, Catherine Dion1, Jennifer R Gowins1, Brian J Mickey2, Jon-Kar Zubieta2, Scott A Langenecker3,2.   

Abstract

Predicting treatment response for major depressive disorder can provide a tremendous benefit for our overstretched health care system by reducing number of treatments and time to remission, thereby decreasing morbidity. The present study used neural and performance predictors during a cognitive control task to predict treatment response (% change in Hamilton Depression Rating Scale pre- to post-treatment). Forty-nine individuals diagnosed with major depressive disorder were enrolled with intent to treat in the open-label study; 36 completed treatment, had useable data, and were included in most data analyses. Participants included in the data analysis sample received treatment with escitalopram (n = 22) or duloxetine (n = 14) for 10 weeks. Functional MRI and performance during a Parametric Go/No-go test were used to predict per cent reduction in Hamilton Depression Rating Scale scores after treatment. Haemodynamic response function-based contrasts and task-related independent components analysis (subset of sample: n = 29) were predictors. Independent components analysis component beta weights and haemodynamic response function modelling activation during Commission errors in the rostral and dorsal anterior cingulate, mid-cingulate, dorsomedial prefrontal cortex, and lateral orbital frontal cortex predicted treatment response. In addition, more commission errors on the task predicted better treatment response. Together in a regression model, independent component analysis, haemodynamic response function-modelled, and performance measures predicted treatment response with 90% accuracy (compared to 74% accuracy with clinical features alone), with 84% accuracy in 5-fold, leave-one-out cross-validation. Convergence between performance markers and functional magnetic resonance imaging, including novel independent component analysis techniques, achieved high accuracy in prediction of treatment response for major depressive disorder. The strong link to a task paradigm provided by use of independent component analysis is a potential breakthrough that can inform ways in which prediction models can be integrated for use in clinical and experimental medicine studies.
© The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  duloxetine; escitalopram; functional MRI; independent components analysis; major depressive disorder

Mesh:

Substances:

Year:  2017        PMID: 28122876      PMCID: PMC5278310          DOI: 10.1093/brain/aww326

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  69 in total

1.  Confidence in recognition memory for words: dissociating right prefrontal roles in episodic retrieval.

Authors:  R N Henson; M D Rugg; T Shallice; R J Dolan
Journal:  J Cogn Neurosci       Date:  2000-11       Impact factor: 3.225

Review 2.  An fMRI study of Stroop word-color interference: evidence for cingulate subregions subserving multiple distributed attentional systems.

Authors:  B S Peterson; P Skudlarski; J C Gatenby; H Zhang; A W Anderson; J C Gore
Journal:  Biol Psychiatry       Date:  1999-05-15       Impact factor: 13.382

3.  Improved optimization for the robust and accurate linear registration and motion correction of brain images.

Authors:  Mark Jenkinson; Peter Bannister; Michael Brady; Stephen Smith
Journal:  Neuroimage       Date:  2002-10       Impact factor: 6.556

Review 4.  Predictors of response to antidepressants general principles and clinical implications.

Authors:  Andrew A Nierenberg
Journal:  Psychiatr Clin North Am       Date:  2003-06

5.  Improved combination of spiral-in/out images for BOLD fMRI.

Authors:  Gary H Glover; Moriah E Thomason
Journal:  Magn Reson Med       Date:  2004-04       Impact factor: 4.668

Review 6.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

7.  Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Authors:  Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie M Biggs; G K Balasubramani; Maurizio Fava
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

Review 8.  Depression: perspectives from affective neuroscience.

Authors:  Richard J Davidson; Diego Pizzagalli; Jack B Nitschke; Katherine Putnam
Journal:  Annu Rev Psychol       Date:  2002       Impact factor: 24.137

9.  An FMRI-compatible Symbol Search task.

Authors:  Spencer W Liebel; Uraina S Clark; Xiaomeng Xu; Hannah H Riskin-Jones; Brittany E Hawkshead; Nicolette F Schwarz; Donald Labbe; Beth A Jerskey; Lawrence H Sweet
Journal:  J Int Neuropsychol Soc       Date:  2015-03-20       Impact factor: 2.892

10.  Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.

Authors:  B R Godlewska; R Norbury; S Selvaraj; P J Cowen; C J Harmer
Journal:  Psychol Med       Date:  2012-04-25       Impact factor: 7.723

View more
  20 in total

1.  Developmental changes in resting-state functional networks among individuals with and without internalizing psychopathologies.

Authors:  Katie L Burkhouse; Jonathan P Stange; Rachel H Jacobs; Runa Bhaumik; Katie L Bessette; Amy T Peters; Natania A Crane; Kayla A Kreutzer; Kate Fitzgerald; Christopher S Monk; Robert C Welsh; K Luan Phan; Scott A Langenecker
Journal:  Depress Anxiety       Date:  2018-12-05       Impact factor: 6.505

Review 2.  Progress in Elucidating Biomarkers of Antidepressant Pharmacological Treatment Response: A Systematic Review and Meta-analysis of the Last 15 Years.

Authors:  G Voegeli; M L Cléry-Melin; N Ramoz; P Gorwood
Journal:  Drugs       Date:  2017-12       Impact factor: 9.546

Review 3.  A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression.

Authors:  Katie L Bessette; Aimee J Karstens; Natania A Crane; Amy T Peters; Jonathan P Stange; Kathleen H Elverman; Sarah Shizuko Morimoto; Sara L Weisenbach; Scott A Langenecker
Journal:  Neuropsychol Rev       Date:  2020-01-15       Impact factor: 7.444

4.  The Translational Potential of Neuroimaging Genomic Analyses To Diagnosis And Treatment In The Mental Disorders.

Authors:  Jiayu Chen; Jingyu Liu; Vince D Calhoun
Journal:  Proc IEEE Inst Electr Electron Eng       Date:  2019-05-09       Impact factor: 10.961

5.  Predicting response to psychiatric surgery: a systematic review of neuroimaging findings.

Authors:  Benjamin Davidson; Hrishikesh Suresh; Maged Goubran; Jennifer S Rabin; Ying Meng; Karim Mithani; Christopher B Pople; Peter Giacobbe; Clement Hamani; Nir Lipsman
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

6.  Differences in the cognitive profile of depression between racial groups.

Authors:  Jon E Grant; Michael Harries; Samuel R Chamberlain
Journal:  Ann Clin Psychiatry       Date:  2018-02       Impact factor: 1.567

7.  Disrupted engagement of networks supporting hot and cold cognition in remitted major depressive disorder.

Authors:  Jonathan P Stange; Lisanne M Jenkins; Elissa J Hamlat; Katie L Bessette; Sophie R DelDonno; Leah R Kling; Alessandra M Passarotti; K Luan Phan; Heide Klumpp; Kelly A Ryan; Scott A Langenecker
Journal:  J Affect Disord       Date:  2017-10-09       Impact factor: 4.839

8.  Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review.

Authors:  Ida Seeberg; Hanne L Kjaerstad; Kamilla W Miskowiak
Journal:  Front Psychiatry       Date:  2018-07-26       Impact factor: 4.157

9.  Pathways to Neuroprediction: Opportunities and challenges to prediction of treatment response in depression.

Authors:  Scott A Langenecker; Natania A Crane; Lisanne M Jenkins; K Luan Phan; Heide Klumpp
Journal:  Curr Behav Neurosci Rep       Date:  2018-01-24

10.  Using Network Parcels and Resting-State Networks to Estimate Correlates of Mood Disorder and Related Research Domain Criteria Constructs of Reward Responsiveness and Inhibitory Control.

Authors:  Scott A Langenecker; Mindy Westlund Schreiner; Leah R Thomas; Katie L Bessette; Sophia R DelDonno; Lisanne M Jenkins; Rebecca E Easter; Jonathan P Stange; Stephanie L Pocius; Alina Dillahunt; Tiffany M Love; K Luan Phan; Vincent Koppelmans; Martin Paulus; Martin A Lindquist; Brian Caffo; Brian J Mickey; Robert C Welsh
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.